Evidence map›Paper›PMID 25412185›Full record

ArticlePLoS neglected tropical diseases2014

Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model.

Flora Engelmann, Laurence Josset, Thomas Girke, Byung Park, Alex Barron, Jesse Dewane, Erika Hammarlund, Anne Lewis, Michael K Axthelm, Mark K Slifka and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Bis(Benzofuran-1,3-International journal of molecular sciences · 2022
    Article
  18. Review
  19. Article
  20. The Present and Future of Yellow Fever Vaccines.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Flora EngelmannDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, United States of America.
Laurence JossetLaboratoire de Virologie Est, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Bron, France.
Thomas GirkeDepartment of Botany and Plant Sciences, University of California Riverside, Riverside, California, United States of America.
Byung ParkPublic Health and Preventive Medicine, Oregon Health and Science University, Portland, Oregon, United States of America.
Alex BarronVaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, Oregon, United States of America.
Jesse DewaneDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Erika HammarlundDivision of Neuroscience, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Anne LewisDivision of Comparative Medicine, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Michael K AxthelmVaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, Oregon, United States of America; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Mark K SlifkaDivision of Neuroscience, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Ilhem MessaoudiDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, United States of America; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Portland, Oregon, United States of America; Division of Neuroscience, Oregon National Primate Research Center, Portland, Oregon, United States of America.
Oregon National Primate Research Center · USOregon Health & Science University · USUniversity of California, Riverside · USHospices Civils de Lyon · FR

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
The Burden of Chikungunya and Dengue Infection in KenyaU54AI081680 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI AXTHELM, MICHAEL K · 2009 to 2013
$40.4M
Development of a Yellow Fever Vaccine for Vulnerable PopulationR44AI079898 · NIAID · NAJIT TECHNOLOGIES, INC. · PI AMANNA, IAN JAMES, SLIFKA, MARK K · 2011 to 2020
$6.2M
Impact of immune senescence on herpes zoster in a nonhuman primate modelR01AG037042 · NIA · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI MESSAOUDI, ILHEM · 2010 to 2014
$2.3M
NIAID NIH HHS R44 AI079898NIAID NIH HHS U54 AI081680NIA NIH HHS R01 AG037042NIH HHS 8P51 OD011092-53NIH HHS P51 OD011092
6 · The paper itself

Abstract

Infection with yellow fever virus (YFV), an explosively replicating flavivirus, results in viral hemorrhagic disease characterized by cardiovascular shock and multi-organ failure. Unvaccinated populations experience 20 to 50% fatality. Few studies have examined the pathophysiological changes that occur in humans during YFV infection due to the sporadic nature and remote locations of outbreaks. Rhesus macaques are highly susceptible to YFV infection, providing a robust animal model to investigate host-pathogen interactions. In this study, we characterized disease progression as well as alterations in immune system homeostasis, cytokine production and gene expression in rhesus macaques infected with the virulent YFV strain DakH1279 (YFV-DakH1279). Following infection, YFV-DakH1279 replicated to high titers resulting in viscerotropic disease with ∼72% mortality. Data presented in this manuscript demonstrate for the first time that lethal YFV infection results in profound lymphopenia that precedes the hallmark changes in liver enzymes and that although tissue damage was noted in liver, kidneys, and lymphoid tissues, viral antigen was only detected in the liver. These observations suggest that additional tissue damage could be due to indirect effects of viral replication. Indeed, circulating levels of several cytokines peaked shortly before euthanasia. Our study also includes the first description of YFV-DakH1279-induced changes in gene expression within peripheral blood mononuclear cells 3 days post-infection prior to any clinical signs. These data show that infection with wild type YFV-DakH1279 or live-attenuated vaccine strain YFV-17D, resulted in 765 and 46 differentially expressed genes (DEGs), respectively. DEGs detected after YFV-17D infection were mostly associated with innate immunity, whereas YFV-DakH1279 infection resulted in dysregulation of genes associated with the development of immune response, ion metabolism, and apoptosis. Therefore, WT-YFV infection is associated with significant changes in gene expression that are detectable before the onset of clinical symptoms and may influence disease progression and outcome of infection.

Indexed as

Host-Pathogen InteractionsAnimalsAntigens, ViralDisease Models, AnimalDisease ProgressionFemaleGene Expression Regulation, ViralHumansKidneyLeukocytes, MononuclearLiverLymphopeniaMacaca mulattaMultiple Organ FailureNecrosisSpleenAntigens, ViralVaccines, AttenuatedYellow Fever Vaccine

Identifiers

PMID25412185
PMCPMC4238990
OpenAlexW2082094974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.